Suzanne M. Hanlon, Secretary, General Counsel & VP HR at Zynerba Pharmaceuticals, Inc. (ZYNE), bought 3,000 shares at $17.92 ($54K) on 2015-08-05, disclosed to the SEC on 2016-08-17.
Open-market purchase of $54k ZYNE by Secretary, General Counsel & VP HR. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.